Longport, Inc. develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States. It offers EPISCAN I-200, a high frequency ultrasound imaging system that utilizes ultrasound at frequencies between 20 and 50MHz to image the skin and underlying soft tissue. The company's products are used in wound assessment, wound prevention, clinical dermatology,...
Its market capitalization was $2,308 as of October 8, 2026.
Figures from company filings and market data; market data as of October 8, 2026.
No profile data available.